ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 191 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2018. The put-call ratio across all filers is 1.26 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $262,000 | -12.7% | 5,903 | -23.0% | 0.00% | -50.0% |
| Q2 2018 | $300,000 | +7.1% | 7,663 | +97.7% | 0.00% | 0.0% |
| Q1 2018 | $280,000 | -14.9% | 3,876 | -22.3% | 0.00% | 0.0% |
| Q4 2017 | $329,000 | +31.6% | 4,991 | 0.0% | 0.00% | +100.0% |
| Q3 2017 | $250,000 | -21.1% | 4,991 | -27.2% | 0.00% | -50.0% |
| Q2 2017 | $317,000 | +24.8% | 6,854 | -4.6% | 0.00% | 0.0% |
| Q1 2017 | $254,000 | +59.7% | 7,188 | -43.4% | 0.00% | +100.0% |
| Q4 2016 | $159,000 | -11.2% | 12,691 | +19.7% | 0.00% | 0.0% |
| Q1 2016 | $179,000 | -40.7% | 10,599 | +187.2% | 0.00% | -50.0% |
| Q2 2015 | $302,000 | -0.3% | 3,691 | +12.7% | 0.00% | 0.0% |
| Q1 2015 | $303,000 | +106.1% | 3,276 | -69.4% | 0.00% | +100.0% |
| Q4 2013 | $147,000 | – | 10,693 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 3,791,300 | $3,715,474 | 4.82% |
| Two Seas Capital LP | 7,672,170 | $7,518,727 | 1.51% |
| Parkman Healthcare Partners LLC | 1,997,071 | $1,957,130 | 0.36% |
| Monaco Asset Management SAM | 1,171,779 | $1,148,343 | 0.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,850,000 | $1,813,000 | 0.26% |
| Ikarian Capital, LLC | 1,737,636 | $1,702,883 | 0.20% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 3,189,517 | $3,125,727 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 1,116,655 | $1,094 | 0.09% |
| XTX Topco Ltd | 519,129 | $508,746 | 0.09% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 60,000 | $58,800 | 0.08% |